vaccine

Innovations in viral vector development 3:34
Innovations in viral vector development
Nathalie Clement • 27 Jan 2022
Medical applications of polyhydroxyalkanoates 2:01
Medical applications of polyhydroxyalkanoates
Ipsita Roy • 11 Nov 2021
Learnings from the COVID-19 pandemic for the advanced therapies sector 2:04
Learnings from the COVID-19 pandemic for the advanced therapies sector
Miguel Forte • 5 Oct 2021
The potential of oncolytic adenoviral vectors 1:32
The potential of oncolytic adenoviral vectors
Margarita Romanenko • 13 May 2021
What can the field learn from the COVID-19 pandemic? 2:45
What can the field learn from the COVID-19 pandemic?
Amy DuRoss • 8 Apr 2021
The lasting impact of COVID-19 on the CGT sector 3:10
The lasting impact of COVID-19 on the CGT sector
Stephen Ward • 14 Apr 2021
Novel oncolytic Ad6 vectors for cancer therapy 2:05
Novel oncolytic Ad6 vectors for cancer therapy
Margarita Romanenko • 13 May 2021
Exosome-based mRNA vaccines against SARS-CoV-2 2:07
Exosome-based mRNA vaccines against SARS-CoV-2
Linda Marban • 19 May 2021
Regulating gene therapies: what can be learned from COVID-19? 1:46
Regulating gene therapies: what can be learned from COVID-19?
Nicole Faust • 9 Apr 2021
Building partnerships between patients and industry 4:18
Building partnerships between patients and industry
Durhane Wong-Rieger • 6 Apr 2021
Educating patients in cell and gene therapies 1:56
Educating patients in cell and gene therapies
Durhane Wong-Rieger • 6 Apr 2021
The future impact of COVID-19 on the gene therapy sector 2:12
The future impact of COVID-19 on the gene therapy sector
Nicole Faust • 9 Apr 2021
The content of VJRegenMed is intended for healthcare professionals